These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 22201996)
1. Prognostic relevance of the expressions of CAV1 and TES genes on 7q31 in melanoma. Vizkeleti L; Ecsedi S; Rakosy Z; Begany A; Emri G; Toth R; Orosz A; Szollosi AG; Mehes G; Adany R; Balazs M Front Biosci (Elite Ed); 2012 Jan; 4(5):1802-12. PubMed ID: 22201996 [TBL] [Abstract][Full Text] [Related]
2. [Biological role and prognostic significance of genetic alterations in human malignant melanomas]. Vízkeleti L Magy Onkol; 2015 Sep; 59(3):268-72. PubMed ID: 26339916 [TBL] [Abstract][Full Text] [Related]
3. Extensive analysis of the 7q31 region in human prostate tumors supports TES as the best candidate tumor suppressor gene. Chêne L; Giroud C; Desgrandchamps F; Boccon-Gibod L; Cussenot O; Berthon P; Latil A Int J Cancer; 2004 Sep; 111(5):798-804. PubMed ID: 15252854 [TBL] [Abstract][Full Text] [Related]
4. Extensive analysis of D7S486 in primary gastric cancer supports TESTIN as a candidate tumor suppressor gene. Ma H; Weng D; Chen Y; Huang W; Pan K; Wang H; Sun J; Wang Q; Zhou Z; Wang H; Xia J Mol Cancer; 2010 Jul; 9():190. PubMed ID: 20626849 [TBL] [Abstract][Full Text] [Related]
5. Expression changes of CAV1 and EZH2, located on 7q31 approximately q36, are rarely related to genomic alterations in primary prostate carcinoma. Bachmann N; Haeusler J; Luedeke M; Kuefer R; Perner S; Assum G; Paiss T; Hoegel J; Vogel W; Maier C Cancer Genet Cytogenet; 2008 Apr; 182(2):103-10. PubMed ID: 18406871 [TBL] [Abstract][Full Text] [Related]
6. EGFR gene copy number alterations in primary cutaneous malignant melanomas are associated with poor prognosis. Rákosy Z; Vízkeleti L; Ecsedi S; Vokó Z; Bégány A; Barok M; Krekk Z; Gallai M; Szentirmay Z; Adány R; Balázs M Int J Cancer; 2007 Oct; 121(8):1729-37. PubMed ID: 17594688 [TBL] [Abstract][Full Text] [Related]
7. Clinical significance of Caveolin-1, Caveolin-2 and HER2/neu mRNA expression in human breast cancer. Sagara Y; Mimori K; Yoshinaga K; Tanaka F; Nishida K; Ohno S; Inoue H; Mori M Br J Cancer; 2004 Aug; 91(5):959-65. PubMed ID: 15305200 [TBL] [Abstract][Full Text] [Related]
8. Chromosome 7q31 POAG locus: ocular expression of caveolins and lack of association with POAG in a US cohort. Kuehn MH; Wang K; Roos B; Stone EM; Kwon YH; Alward WL; Mullins RF; Fingert JH Mol Vis; 2011 Feb; 17():430-5. PubMed ID: 21321670 [TBL] [Abstract][Full Text] [Related]
9. Cross-talk between Dopachrome Tautomerase and Caveolin-1 Is Melanoma Cell Phenotype-specific and Potentially Involved in Tumor Progression. Popa IL; Milac AL; Sima LE; Alexandru PR; Pastrama F; Munteanu CVA; Negroiu G J Biol Chem; 2016 Jun; 291(24):12481-12500. PubMed ID: 27053106 [TBL] [Abstract][Full Text] [Related]
10. TES was epigenetically silenced and suppressed the epithelial-mesenchymal transition in breast cancer. Yongbin Y; Jinghua L; Zhanxue Z; Aimin Z; Youchao J; Yanhong S; Manjing J Tumour Biol; 2014 Nov; 35(11):11381-9. PubMed ID: 25119600 [TBL] [Abstract][Full Text] [Related]
11. The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma. Ando T; Ishiguro H; Kimura M; Mitsui A; Mori Y; Sugito N; Tomoda K; Mori R; Harada K; Katada T; Ogawa R; Fujii Y; Kuwabara Y Oncol Rep; 2007 Sep; 18(3):601-9. PubMed ID: 17671707 [TBL] [Abstract][Full Text] [Related]
12. The role of CCND1 alterations during the progression of cutaneous malignant melanoma. Vízkeleti L; Ecsedi S; Rákosy Z; Orosz A; Lázár V; Emri G; Koroknai V; Kiss T; Ádány R; Balázs M Tumour Biol; 2012 Dec; 33(6):2189-99. PubMed ID: 23001925 [TBL] [Abstract][Full Text] [Related]
13. Testin is a tumor suppressor and prognostic marker in breast cancer. Zhu J; Li X; Kong X; Moran MS; Su P; Haffty BG; Yang Q Cancer Sci; 2012 Dec; 103(12):2092-101. PubMed ID: 22957844 [TBL] [Abstract][Full Text] [Related]
14. CAV1 inhibits metastatic potential in melanomas through suppression of the integrin/Src/FAK signaling pathway. Trimmer C; Whitaker-Menezes D; Bonuccelli G; Milliman JN; Daumer KM; Aplin AE; Pestell RG; Sotgia F; Lisanti MP; Capozza F Cancer Res; 2010 Oct; 70(19):7489-99. PubMed ID: 20709760 [TBL] [Abstract][Full Text] [Related]
15. Significant association of caveolin-1 (CAV1) genotypes with prostate cancer susceptibility in Taiwan. Wu HC; Chang CH; Tsou YA; Tsai CW; Lin CC; Bau DT Anticancer Res; 2011 Feb; 31(2):745-9. PubMed ID: 21378366 [TBL] [Abstract][Full Text] [Related]
16. Chromosomal imbalances in primary and metastatic melanomas: over-representation of essential telomerase genes. Pirker C; Holzmann K; Spiegl-Kreinecker S; Elbling L; Thallinger C; Pehamberger H; Micksche M; Berger W Melanoma Res; 2003 Oct; 13(5):483-92. PubMed ID: 14512790 [TBL] [Abstract][Full Text] [Related]
17. The clinicopathological significance of miR-133a in colorectal cancer. Wan TM; Lam CS; Ng L; Chow AK; Wong SK; Li HS; Man JH; Lo OS; Foo D; Cheung A; Yau T; Poon JT; Poon RT; Law WL; Pang RW Dis Markers; 2014; 2014():919283. PubMed ID: 25104873 [TBL] [Abstract][Full Text] [Related]
18. Genes encoding human caveolin-1 and -2 are co-localized to the D7S522 locus (7q31.1), a known fragile site (FRA7G) that is frequently deleted in human cancers. Engelman JA; Zhang XL; Lisanti MP FEBS Lett; 1998 Oct; 436(3):403-10. PubMed ID: 9801158 [TBL] [Abstract][Full Text] [Related]
19. A molecular cytogenetic analysis of 7q31 in prostate cancer. Jenkins RB; Qian J; Lee HK; Huang H; Hirasawa K; Bostwick DG; Proffitt J; Wilber K; Lieber MM; Liu W; Smith DI Cancer Res; 1998 Feb; 58(4):759-66. PubMed ID: 9485032 [TBL] [Abstract][Full Text] [Related]
20. Caveolin-1 is a risk factor for postsurgery metastasis in preclinical melanoma models. Lobos-Gonzalez L; Aguilar-Guzmán L; Fernandez JG; Muñoz N; Hossain M; Bieneck S; Silva V; Burzio V; Sviderskaya EV; Bennett DC; Leyton L; Quest AF Melanoma Res; 2014 Apr; 24(2):108-19. PubMed ID: 24500501 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]